These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 19277223

  • 21. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [Abstract] [Full Text] [Related]

  • 22. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
    da Mota LM, Dos Santos Neto LL, de Carvalho JF, Pereira IA, Burlingame R, Ménard HA, Laurindo IM.
    Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
    [Abstract] [Full Text] [Related]

  • 23. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 24. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 25. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement.
    Ribeiro SL, Pereira HL, Silva NP, Neves RM, Sato EI.
    Braz J Med Biol Res; 2008 Nov 15; 41(11):1005-10. PubMed ID: 19099154
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.
    de Siqueira MB, da Mota LM, Couto SC, Muniz-Junqueira MI.
    BMC Musculoskelet Disord; 2015 Jun 30; 16():159. PubMed ID: 26123215
    [Abstract] [Full Text] [Related]

  • 29. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y, Wang YF, Wang KL, Lv FF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun 18; 46(3):478-82. PubMed ID: 24943033
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH, Nurdayana AK, Rusni D, Azwany Y.
    Int J Rheum Dis; 2010 Oct 18; 13(4):335-9. PubMed ID: 21199468
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C, Zofotă S, Bojincă V, Ionescu R.
    Rom J Intern Med; 2013 Oct 18; 51(3-4):179-87. PubMed ID: 24620631
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Examination of rheumatoid factor and other serum markers in rheumatoid arthritis].
    Hiura K, Iwaki-Egawa S, Matsuno H, Watanabe Y.
    Yakugaku Zasshi; 2005 Nov 18; 125(11):881-7. PubMed ID: 16272809
    [Abstract] [Full Text] [Related]

  • 37. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y, Koopah S, Jamshidi AR, Amirzargar AA, Massoud A, Kiani A, Nicknam MH, Nazari B, Nikbin B.
    Iran J Allergy Asthma Immunol; 2014 Jun 18; 13(3):147-56. PubMed ID: 24659118
    [Abstract] [Full Text] [Related]

  • 38. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.
    Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H, Inanc M.
    Clin Rheumatol; 2007 Jan 18; 26(1):17-23. PubMed ID: 16538391
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis.
    Liao KP, Batra KL, Chibnik L, Schur PH, Costenbader KH.
    Ann Rheum Dis; 2008 Nov 18; 67(11):1557-61. PubMed ID: 18234714
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.